iSpecimen Inc. (NASDAQ:ISPC) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET

Company Participants

Allison Soss - Investor Relations

Christopher Ianelli - Chief Executive Officer and President

Tracy Curley - Chief Financial Officer

Jill Mullan - Chief Operating Officer

Conference Call Participants

Matthew Hewitt - Craig-Hallum Capital Group

Constantine Davides - EF Hutton

Operator

Good day, everyone, and welcome to iSpecimen's First Quarter 2022 Conference Call. [Operator Instructions] This conference is being recorded. A replay of today's call will be available on the Investor Relations section of iSpecimen's website and will remain posted there for the next 30 days.

I will now hand the call over to Allison Soss, Investor Relations for introductions and the reading of the safe harbor statement. Please go ahead.

Allison Soss

Thank you, operator. Good morning, everyone, and welcome to iSpecimen's First Quarter 2022 Results Conference Call. With us on today's call are Christopher Ianelli, iSpecimen's Chief Executive Officer and President; Tracy Curley, Chief Financial Officer; and Jill Mullan, Chief Operating Officer. Before we begin, I would like to remind you that today's call contains certain forward-looking statements from our management made within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities and Exchange Act of 1934 as amended, concerning future events.

Words such as may, should, projects, expects, intends, plans, believes, anticipates, hopes, estimates and variations of such words and similar expressions are intended to identify forward-looking statements. These statements are subject to numerous conditions, many of which are beyond the control of the company, including those set forth in the Risk Factors section of the company's Form 10-K for the year ended December 31, 2021, filed with the SEC.

Copies of this document are available on the SEC's website at www.sec.gov. Actual results may differ materially from those expressed or implied by such forward-looking statements. The company undertakes no obligation to update these statements or revisions or changes after the date of this call, except as required by law. Now it is my pleasure to introduce Chris Ianelli, CEO and President of iSpecimen. Chris, please go ahead.

Christopher Ianelli

Thank you, Allison, and good morning, everyone. Thank you for joining us for today on our First Quarter 2022 Earnings Conference Call. I'm excited to provide you with an update on our progress following 3 completed quarters of operation as a public company. With me are Tracy Curley, our Chief Financial Officer; and Jill Mullan, our Chief Operating Officer.